Media Summary: This short animation combines the lifework of Professor Claude Wischik, CEO of TauRx and the TauRx team on Sonawane, et al. “Baicalein inhibits heparin-induced Professor Claude Wischik, CEO TauRx Therapeutics Ltd, and Dr Sonya Miller, Medical Oversight Lead, present these educational ...

Tau Aggregation Assay - Detailed Analysis & Overview

This short animation combines the lifework of Professor Claude Wischik, CEO of TauRx and the TauRx team on Sonawane, et al. “Baicalein inhibits heparin-induced Professor Claude Wischik, CEO TauRx Therapeutics Ltd, and Dr Sonya Miller, Medical Oversight Lead, present these educational ... 2min intro video - Kayleigh Mason and Jae Young Seo. Sonya Miller, MBBS, FFARCS, FANZCA, TauRx Therapeutics Ltd., Aberdeen, UK, discusses the promise of A new study by UT Southwestern researchers demonstrates that toxic

Abhishek Ankur Balmik and Subashchandrabose Chinnathambi. “Methylation as a key regulator of Alicia Algeciras-Schimnich, PhD, Mayo Clinic, Rochester, MN, explains her research evaluating the performance of blood-based ... Sonya Miller, MBBS, FFARCS, FANZCA, TauRx Therapeutics Ltd., Aberdeen, UK, discusses the recent double-blind, randomized, ... Irving E. Vega, Ph.D., Associate Professor, Michigan State University Department of Translational Neuroscience. Laura Blair, PhD, University of South Florida, and Brian Blagg, PhD, University of Notre Dame, 2023 Harrington ... A stochastic model showing the process of

The UK DRI at UCL is pleased to welcome Dr Simon Dujardin (Massachusetts General Hospital & Harvard Medical School). "

Photo Gallery

Aggregation Assays Using Hyperphosphorylated Tau Protein l Protocol Preview
Tau aggregation assay
In Vitro Assay for Studying Tau Protein aggregation and Drug Screening | Protocol Preview
Tau Protein Pathology in Alzheimer's Disease
Baicalein inhibits heparin induced Tau aggregation by initializing Tau oligomer formation
Targeting Tau in Alzheimer's Disease
Tau Aggregation Study by Lentiviral-mediated Transduction of Neurons | Protocol Preview
Tau Aggregation is Altered by Variations in its Projection Domain
The promise of tau aggregation inhibitors in dementia
Potential Role of Extracellular Tau in Development and Spread of Tauopathy
Research Highlight: Toxic tau aggregates determines type of dementia
Methylation regulates Tau aggregation and neuronal health in Alzheimer’s disease
View Detailed Profile
Aggregation Assays Using Hyperphosphorylated Tau Protein l Protocol Preview

Aggregation Assays Using Hyperphosphorylated Tau Protein l Protocol Preview

Watch the Full Video at ...

Tau aggregation assay

Tau aggregation assay

This video is about

In Vitro Assay for Studying Tau Protein aggregation and Drug Screening | Protocol Preview

In Vitro Assay for Studying Tau Protein aggregation and Drug Screening | Protocol Preview

Watch the Full Video at ...

Tau Protein Pathology in Alzheimer's Disease

Tau Protein Pathology in Alzheimer's Disease

This short animation combines the lifework of Professor Claude Wischik, CEO of TauRx and the TauRx team on

Baicalein inhibits heparin induced Tau aggregation by initializing Tau oligomer formation

Baicalein inhibits heparin induced Tau aggregation by initializing Tau oligomer formation

Sonawane, et al. “Baicalein inhibits heparin-induced

Targeting Tau in Alzheimer's Disease

Targeting Tau in Alzheimer's Disease

Professor Claude Wischik, CEO TauRx Therapeutics Ltd, and Dr Sonya Miller, Medical Oversight Lead, present these educational ...

Tau Aggregation Study by Lentiviral-mediated Transduction of Neurons | Protocol Preview

Tau Aggregation Study by Lentiviral-mediated Transduction of Neurons | Protocol Preview

Watch the Full Video at ...

Tau Aggregation is Altered by Variations in its Projection Domain

Tau Aggregation is Altered by Variations in its Projection Domain

2min intro video - Kayleigh Mason and Jae Young Seo.

The promise of tau aggregation inhibitors in dementia

The promise of tau aggregation inhibitors in dementia

Sonya Miller, MBBS, FFARCS, FANZCA, TauRx Therapeutics Ltd., Aberdeen, UK, discusses the promise of

Potential Role of Extracellular Tau in Development and Spread of Tauopathy

Potential Role of Extracellular Tau in Development and Spread of Tauopathy

Effects of Anti-

Research Highlight: Toxic tau aggregates determines type of dementia

Research Highlight: Toxic tau aggregates determines type of dementia

A new study by UT Southwestern researchers demonstrates that toxic

Methylation regulates Tau aggregation and neuronal health in Alzheimer’s disease

Methylation regulates Tau aggregation and neuronal health in Alzheimer’s disease

Abhishek Ankur Balmik and Subashchandrabose Chinnathambi. “Methylation as a key regulator of

Comparing the performance of blood-based amyloid and tau assays

Comparing the performance of blood-based amyloid and tau assays

Alicia Algeciras-Schimnich, PhD, Mayo Clinic, Rochester, MN, explains her research evaluating the performance of blood-based ...

The Phase III LUCIDITY trial: a tau aggregation inhibitor in patients with Alzheimer’s disease

The Phase III LUCIDITY trial: a tau aggregation inhibitor in patients with Alzheimer’s disease

Sonya Miller, MBBS, FFARCS, FANZCA, TauRx Therapeutics Ltd., Aberdeen, UK, discusses the recent double-blind, randomized, ...

Tau Biology and Pathology

Tau Biology and Pathology

Irving E. Vega, Ph.D., Associate Professor, Michigan State University Department of Translational Neuroscience.

Disrupting Tau Aggregation: A New Approach to Alzheimer's Therapy

Disrupting Tau Aggregation: A New Approach to Alzheimer's Therapy

Laura Blair, PhD, University of South Florida, and Brian Blagg, PhD, University of Notre Dame, 2023 Harrington ...

Tau aggregation and transmission: Smoldyn Modelling

Tau aggregation and transmission: Smoldyn Modelling

A stochastic model showing the process of

Studying Tau Aggregation Using FRET

Studying Tau Aggregation Using FRET

This video explains a study on how

Tau molecular diversity contributes to clinical heterogeneity in AD - Dr Simon Dujardin

Tau molecular diversity contributes to clinical heterogeneity in AD - Dr Simon Dujardin

The UK DRI at UCL is pleased to welcome Dr Simon Dujardin (Massachusetts General Hospital & Harvard Medical School). "

Amyloid Plaques and Tau Assembly in Alzheimer’s Disease

Amyloid Plaques and Tau Assembly in Alzheimer’s Disease

How do amyloid beta and